Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
40.79
-1.08 (-2.58%)
At close: Aug 13, 2026, 4:00 PM EDT
41.00
+0.21 (0.51%)
After-hours: Aug 13, 2026, 7:34 PM EDT
Rigel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Rigel Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $55.6. The average 1-year stock price forecast is 36.31% higher than the current stock price, while the lowest is $40 (-1.94%) and the highest is $83 (+103.48%).
Price Target: $55.6 (+36.31%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rigel Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +103.48% | Aug 6, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $43 | Hold | Maintains | $43 | +5.42% | Aug 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $57 | Buy | Reiterates | $57 | +39.74% | Aug 5, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $40 | Hold | Maintains | $40 | -1.94% | May 13, 2026 |
Financial Forecast
Revenue This Year
310.44M
from 294.28M
Increased by 5.49%
Revenue Next Year
355.76M
from 310.44M
Increased by 14.60%
EPS This Year
3.89
from 6.43
Decreased by -39.53%
EPS Next Year
4.48
from 3.89
Increased by 15.15%
EPS and Forward PE are based on non-GAAP adjusted numbers.